Seres Therapeutics Inc
Change company Symbol lookup
Select an option...
MCRB Seres Therapeutics Inc
TC TuanChe Ltd
ENSG Ensign Group Inc
INO Inovio Pharmaceuticals Inc
WHR Whirlpool Corp
TTOO T2 Biosystems Inc
AAPL Apple Inc
HOKCY Hong Kong and China Gas Co Ltd
NWFFX American Funds New World Fund® Class F-1
CARS Cars.com Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The Company is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens.

Closing Price
$25.65
Day's Change
-1.21 (-4.50%)
Bid
--
Ask
--
B/A Size
--
Day's High
26.24
Day's Low
24.26
Volume
(Heavy Day)
Volume:
2,265,886

10-day average volume:
883,858
2,265,886

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eastman Kodak Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

10:15 am ET August 5, 2020 (BusinessWire) Print

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Eastman Kodak Company ("Kodak" or "the Company") (NYSE: KODK) for potential breaches of fiduciary duty on the part of its directors and management.

If you are a shareholder, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200805005677/en/

SOURCE: The Schall Law Firm

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com 
www.schallfirm.com
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.